Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/28475
Título: Exploring MIA-QSARs for farnesyltransferase inhibitory effect of antimalarial compounds refined by docking simulations
Palavras-chave: Farnesyltransferase Inhibitors
Analysis-QSAR
Docking simulations
Antimalarial compounds
Inibidores da farnesiltransferase
Análise-QSAR
Simulações de encaixe
Compostos antimaláricos
Data do documento: 2012
Editor: Scientific Research
Citação: DEEB, O. et al. Exploring MIA-QSARs for farnesyltransferase inhibitory effect of antimalarial compounds refined by docking simulations. Journal of Biophysical Chemistry, [S. l.], v. 3, n. 1, p. 58-71, 2012.
Resumo: Two series of farnesyltransferase (FTase) inhibi- tors were grouped and their antimalarial activi-ties modeled by means of multivariate image analysis applied to quantitative structure-activ- ity relationship (MIA-QSAR). A reliable model was achieved, with r2 for calibration, external prediction and leave-one-out cross-validation of 0.96, 0.87 and 0.83, respectively. Therefore, bio-logical activities of congeners can be estimated using the QSAR model. The bioactivities of new compounds based on the miscellany of sub-structures of the two classes of FTase inhibitors were predicted using the MIA-QSAR model and the most promising ones were submitted to ADME (absorption, distribution, metabolism and excretion) and docking evaluation. Despite the smaller interaction energy of the two most pro-mising, predicted compounds in comparison to the two most active compounds of the data set, one of the proposed structures did not violate any Lipinski’s rule of five. Therefore, it is either a potential drug or may drive synthesis of similar, improved compounds.
URI: http://file.scirp.org/Html/17180.html
http://repositorio.ufla.br/jspui/handle/1/28475
Aparece nas coleções:DQI - Artigos publicados em periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.